Search

Your search keyword '"Thomas, Katie"' showing total 2,186 results

Search Constraints

Start Over You searched for: Author "Thomas, Katie" Remove constraint Author: "Thomas, Katie"
2,186 results on '"Thomas, Katie"'

Search Results

251. Express Scripts Offers To Cut Insulin Prices

252. Prescription Drugs to Your Door, Nearly as Easy as Ordering Pizza

253. Suits Over Blood Thinner Settled for $775 Million

254. The Digest

255. Eli Lilly, Feeling Heat, Will Sell Half-Price Insulin

256. What Trump's Plan to Cut Drug Prices Could Mean for You

257. We Tried 5 Cold-Weather Experiments. Instant Slushies, Frozen Bubbles and More

258. John Mendelsohn, 82, Leader of Top Cancer Center, Dies

259. F.D.A. Advisers Split on Recommending Approval of the First Oral Drug for Diabetes

260. Shaken by Scandals, Top Cancer Center Restricts Ties to Industry

261. California Ups the Ante as States Take On High Drug Prices

262. Drugmaker Hires Doctor Censured for Pharma Fees

263. Bristol-Myers to Acquire Celgene, Fortifying Roster of Cancer Drugs

264. When Doctors Serve on Corporate Boards

265. A Reckoning at Sloan Kettering

266. Ninth Workshop on the Development of Quantitative Assessment Methodologies based on LIFE-history traits, exploitation characteristics, and other relevant parameters for data-limited stocks (WKLIFE IX)

267. Leading Cancer Doctor Resigns As Editor of Top Medical Journal

268. 'Broken' System Lets Doctors Omit Industry Ties in Journals

269. Doctors and Disclosures

270. Drug Maker Settles Investigation Into Kickbacks

271. Childhood Disability-Related Abuse: A Retrospective Proof-of-Concept Study.

272. Posttraumatic Stress Symptom Severity Mediates the Relationship Between Military Sexual Trauma and Tension Reduction Behaviors in Male and Female Veterans.

274. Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016

280. Maker Deeply Cuts Price Of Steep Cholesterol Drug

281. Sloan Kettering Researchers Correct Record by Revealing Company Ties

282. Cancer Center's Chief Quits Boards of 2 Medical Companies

283. Cancer Center Chairman Faults Former Top Doctor

284. Facing Crisis, Hospital Curbs For-Profit Ties

285. As Crisis Grows, Hospital Shifts Fund-Raising Focus

286. Senate Hopeful Campaigns on Drug Industry Career

287. Hospital's Deal With Start-Up Angers Doctors

288. Prizes Honor Advances in Medicine

289. Cancer Expert Who Failed to Disclose Industry Ties Will Exit Sloan Kettering

290. Lasker Awards Given for Work in Genetics, Anesthesia and Promoting Women in Science

291. Hospital Staff Told to Disclose Industry Ties

292. A Top Doctor Didn't Disclose Corporate Ties

293. Financial Deal, Web of Conflict And a Politician

294. Rebates, a Low-Key Negotiating Tool, Become the Latest Villain Behind Drug Costs

295. Meet the Rebate, the New Villain of High Drug Prices

296. Merck Says It Will Lower Prices on Some Drugs, but Not for Its Biggest Sellers

297. Novartis Bows to Trump, Delaying Price Increases

298. What Does a Drug Cost? It Depends on Where You Live

299. Question for Amazon: Will Pharmacy Industry See It as Partner or Rival?

300. Bare Shelves in the Trauma Ward

Catalog

Books, media, physical & digital resources